FdaApplication
NDA 200045
Identifiers
- fda_app_no: NDA200045
Properties
| Property | Value |
|---|---|
| applicant_name | NOVARTIS PHARMACEUTICALS CORP |
| application_type | NDA |
| approval_date | 2010-12-21 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| AMTURNIDE | ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE | EQ 300MG BASE;EQ 5MG BASE;12.5MG | TABLET;ORAL |
| AMTURNIDE | ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE | EQ 150MG BASE;EQ 5MG BASE;12.5MG | TABLET;ORAL |
| AMTURNIDE | ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE | EQ 300MG BASE;EQ 10MG BASE;25MG | TABLET;ORAL |
| AMTURNIDE | ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE | EQ 300MG BASE;EQ 5MG BASE;25MG | TABLET;ORAL |
| AMTURNIDE | ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE | EQ 300MG BASE;EQ 10MG BASE;12.5MG | TABLET;ORAL |
5 products